News und Analysen
EQS-News: Uni-Bio Science Group Limited 2019 Annual Results Turnover Increased by 54.9% YoY to HK$209.4 million Recording EBITDA of HK$28.4 million Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020
EQS-News: Uni-Bio Science Group Limited 2019 Annual Results Turnover Increased by 54.9% YoY to HK$209.4 million Recording EBITDA of HK$28.4 million Achieved Significant Progress towards Pipeline Product with 2 Product Launches Expected in 2020
EQS-News: Great Bay Bio injected with 2.5 million USD of convertible note
EQS-News: Great Bay Bio injected with 2.5 million USD of convertible note
EQS-News: Great Bay Bio and Boji Medical have Reached Strategic Cooperation to Jointly Develop a Long-Acting Biological and Innovative Anti-Anemia Injection
EQS-News: Great Bay Bio and Boji Medical have Reached Strategic Cooperation to Jointly Develop a Long-Acting Biological and Innovative Anti-Anemia Injection
Uni-Bio Science Group Announces 2023 Annual Results
Uni-Bio Science Group Announces 2023 Annual Results
Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)
Marketing application of Diquafosol Sodium eye drops has been officially accepted by the China National Medical Products Administration (NMPA)
As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
As A Breakthrough Drug For The Expansive Osteoporosis Market, Bogutai® (Teriparatide Injection) Has Been Officially Approved By The China National Medical Products Administration (NMPA)
Uni-Bio Science Group Limited Announces 2023 Interim Results
Uni-Bio Science Group Limited Announces 2023 Interim Results
Uni-Bio Science Group Limited: 2022 Annual Results
Uni-Bio Science Group Limited: 2022 Annual Results
Uni-Bio Science Group Limited: 2022 Interim Results
Uni-Bio Science Group Limited: 2022 Interim Results
EQS-News: Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)
EQS-News: Marketing application of BOGUTAI® (teriparatide injection) has been officially accepted by the China National Medical Products Administration (NMPA)
EQS-News: Uni-Bio Science Group Limited：2021 Annual Results
EQS-News: Uni-Bio Science Group Limited：2021 Annual Results